{"id":17094,"date":"2020-05-28T15:29:51","date_gmt":"2020-05-28T14:29:51","guid":{"rendered":"https:\/\/touchneurology.com\/?post_type=media_gallery&p=17094"},"modified":"2021-08-18T15:43:35","modified_gmt":"2021-08-18T14:43:35","slug":"elena-moro-ean-2020-neurological-implications-of-covid-19-in-europe","status":"publish","type":"media_gallery","link":"https:\/\/touchneurology.com\/covid-19\/conference-hub\/elena-moro-ean-2020-neurological-implications-of-covid-19-in-europe\/","title":{"rendered":"Elena Moro, EAN 2020 \u2013 Neurological Implications of COVID-19 in Europe"},"content":{"rendered":"
EAN Treasurer, Elena Moro<\/strong> (Centre Hospitalier Universitaire de Grenoble, France), kindly took the time to share with us her expert perspective on the neurological implications of COVID-19 in Europe. <\/span><\/p>\n Questions
\n1. What are the neurological implications of COVID-19 in Europe? (<\/span>0:05<\/a>)
\n2. What are the major risks posed by COVID-19 in patients with neurological illness? (<\/span>2:40<\/a>)
\n3. What advice would you give to neurologists facing complex decisions regarding their patients\u2019 treatment plans during the pandemic? (<\/span>4:46<\/a>)<\/span><\/p>\n